Self-Assembled Nanoparticles of Amphiphilic Twin Drug from Floxuridine and Bendamustine for Cancer Therapy

Molecular Pharmaceutics

Volumn 12, Issue 7, 2015, Pages 2328-2336

  Zhang, Ting ^a   Huang, Ping ^a   Shi, Leilei ^a   Su, Yue ^a   Zhou, Linzhu ^a   Zhu, Xinyuan ^a   Yan, Deyue ^a  

^a SHANGHAI JIAO TONG UNIVERSITY   (China)

Author keywords

bendamustine; cancer therapy; floxuridine; nanoparticle; twin drug

Indexed keywords

BENDAMUSTINE; CASPASE 3; FLOXURIDINE; NANOPARTICLE; ANTINEOPLASTIC AGENT; DRUG CARRIER;

ANTINEOPLASTIC ACTIVITY; APOPTOSIS; ARTICLE; CANCER CELL; CANCER CHEMOTHERAPY; CARBON NUCLEAR MAGNETIC RESONANCE; CELL PROLIFERATION; CONTROLLED STUDY; DRUG DELIVERY SYSTEM; DRUG HYDROLYSIS; DRUG RELEASE; HUMAN; HUMAN CELL; IN VITRO STUDY; INTERNALIZATION; MOLECULAR WEIGHT; MULTIDRUG RESISTANCE; PRIORITY JOURNAL; PROTON NUCLEAR MAGNETIC RESONANCE; CHEMICAL PHENOMENA; CHEMISTRY; DRUG EFFECTS; HELA CELL LINE; MCF 7 CELL LINE; NEOPLASMS; PROCEDURES; TUMOR CELL LINE;

ANTINEOPLASTIC AGENTS; BENDAMUSTINE HYDROCHLORIDE; CELL LINE, TUMOR; DRUG CARRIERS; DRUG DELIVERY SYSTEMS; DRUG RESISTANCE, MULTIPLE; FLOXURIDINE; HELA CELLS; HUMANS; HYDROPHOBIC AND HYDROPHILIC INTERACTIONS; MCF-7 CELLS; NANOPARTICLES; NEOPLASMS;

EID: 84936767507     PISSN: 15438384     EISSN: 15438392     Source Type: Journal    
DOI: 10.1021/acs.molpharmaceut.5b00005     Document Type: Article

References (36)

1. Thomas, D. M.; Zalcberg, J. R. 5-Fluorouracil: a pharmacological paradigm in the use of cytotoxics Clin. Exp. Pharmacol. Physiol. 1998, 25, 887-895
2. Nakagawa, H.; Maeda, N.; Tsuzuki, T.; Suzuki, T.; Hirayama, A.; Miyahara, E.; Wada, K. Intracavitary chemotherapy with 5-fluoro-2′-deoxyuridine (FdUrd) in malignant brain tumor Jpn. J. Clin. Oncol. 2001, 31, 251-258
3. Power, D. G.; Kemeny, N. E. The role of floxuridine in metastatic liver disease Mol. Cancer Ther. 2009, 8, 1015-1025
4. Di Stefano, G.; Busi, C.; Fiume, L. Floxuridine coupling with lactosaminated human albumin to increase drug efficacy on liver micrometastases Dig. Liver Dis. 2002, 34, 439-446
5. Grem, J. L. 5-Fluorouracil: forty-plus and still ticking. A review of its preclinical and clinical development Invest. New Drugs 2000, 18, 299-313
6. Xia, Z. P.; Wiebe, L. I.; Miller, G. G.; Knaus, E. E. Synthesis and biological evaluation of butanoate, retinoate, and bis(2,2,2-trichloroethyl)phosphate derivatives of 5-fluoro-2′-deoxyuridine and 2′,5-difluoro-2′-deoxyuridine as potential dual action anticancer prodrugs Arch. Pharm. 1999, 332, 286-294
7. Vig, B. S.; Lorenzi, P. J.; Mittal, S.; Landowski, C. P.; Shin, H.-C.; Mosberg, H. I.; Hilfinger, J. M.; Amidon, G. L. Amino acid ester prodrugs of floxuridine: synthesis and effects of structure, stereochemistry, and site of esterification on the rate of hydrolysis Pharm. Res. 2003, 20, 1381-1388
8. Tsume, Y.; Amidon, G. L. The feasibility of enzyme targeted activation for amino acid/dipeptide monoester prodrugs of floxuridine; cathepsin D as a potential targeted enzyme Molecules 2012, 17, 3672-3689
9. Tsume, Y.; Hilfinger, J. M.; Amidon, G. L. Enhanced cancer cell growth inhibition by dipeptide prodrugs of floxuridine: increased transporter affinity and metabolic stability Mol. Pharmaceutics 2008, 5, 717-727
10. Tobias, S. C.; Borch, R. F. Synthesis and biological studies of novel nucleoside phosphoramidate prodrugs J. Med. Chem. 2001, 44, 4475-4480
11. Landowski, C. P.; Song, X.; Lorenzi, P. L.; Hilfinger, J. M.; Amidon, G. L. Floxuridine amino acid ester prodrugs: enhancing Caco-2 permeability and resistance to glycosidic bond metabolism Pharm. Res. 2005, 22, 1510-1518
12. Landowski, C. P.; Vig, B. S.; Song, X.; Amidon, G. L. Targeted delivery to PEPT1-overexpressing cells: acidic, basic, and secondary floxuridine amino acid ester prodrugs Mol. Cancer Ther. 2005, 4, 659-667
13. Fujii, H. Twin and triplet drugs in opioid research Top. Curr. Chem. 2011, 299, 239-275
14. Peer, D.; Karp, J. M.; Hong, S.; FaroKhzad, O. C.; Margalit, R.; Langer, R. Nanocarriers as an emerging platform for cancer therapy Nat. Nanotechnol. 2007, 2, 751-760
15. Shi, J. J.; Votruba, A. R.; Farokhzad, O. C.; Langer, R. Nanotechnology in drug delivery and tissue engineering: from discovery to applications Nano Lett. 2010, 10, 3223-3230
16. Hubbell, J. H.; Chilkoti, A. Nanomaterials for drug delivery Science 2012, 337, 303-305
17. Sun, T. M.; Zhang, Y. S.; Pang, B.; Hyun, D. C.; Yang, M. X.; Xia, Y. N. Engineered nanoparticles for drug delivery in cancer therapy Angew. Chem., Int. Ed. 2014, 53, 12320-12364
18. Huang, P.; Wang, D. L.; Su, Y.; Huang, W.; Zhou, Y. F.; Cui, D. X.; Zhu, X. Y.; Yan, D. Y. Combination of small molecule prodrug and nanodrug delivery: amphiphilic drug-drug conjugate for cancer therapy J. Am. Chem. Soc. 2014, 136, 11748-11756
19. Shen, Y. Q.; Jin, E. L.; Zhang, B.; Murphy, C. J.; Sui, M. H.; Zhao, J.; Wang, J. Q.; Tang, J. B.; Fan, M. H.; Van Kirk, E.; Murdoch, W. J. Prodrugs forming high drug loading multifunctional nanocapsules for intracellular cancer drug delivery J. Am. Chem. Soc. 2010, 132, 4259-4265
20. Saiyin, W.; Wang, D. L.; Li, L. L.; Zhu, L. J.; Liu, B.; Sheng, L. J.; Li, Y. W.; Zhu, B. S.; Mao, L. M.; Li, G. L.; Zhu, X. Y. Sequential release of autophagy inhibitor and chemotherapeutic drug with polymeric delivery system for oral squamous cell carcinoma therapy Mol. Pharmaceutics 2014, 11, 1662-1675
21. Wang, D.; Chen, H.; Su, Y.; Qiu, F.; Zhu, L.; Huan, X.; Zhu, B.; Yan, D.; Guo, F.; Zhu, X. Supramolecular amphiphilic multiarm hyperbranched copolymer: synthesis, self-assembly and drug delivery applications Polym. Chem. 2013, 4, 85-94
22. Liu, J. Y.; Pang, Y.; Huang, W.; Huang, X. H.; Meng, L. L.; Zhu, X. Y.; Zhou, Y. F.; Yan, D. Y. Bioreducible micelles self-assembled from amphiphilic hyperbranched multiarm copolymer for glutathione-mediated intracellular drug delivery Biomacromolecules 2011, 12, 1567-1577
23. Werner, W.; Herold, M.; Ruffert, K.; Merkle, K.; Brakhage, A.; Leoni, L.; Cheson, B. D. Development history: bendamustine yesterday, today, tomorrow Onkologie 2013, 36, 2-10
24. Chow, K. U.; Boehrer, S.; Geduldig, K.; Krapohl, A.; Hoelzer, D.; Mitrou, P. S.; Weidmann, E. In vitro induction of apoptosis of neoplastic cells in low-grade non-Hodgkin's lymphomas using combinations of established cytotoxic drugs with bendamustine Haematologica 2001, 86, 485-493
25. Ujjani, C.; Cheson, B. D. Bendamustine in the treatment of chronic lymphocytic leukemia Expert Opin. Orphan Drugs 2014, 2, 617-623
26. Scutaru, A. M.; Wenzel, M.; Scheffler, H.; Wolber, G.; Gust, R. Optimization of the N-lost dugs melphalan and bendamustine: synthesis and cytotoxicity of a new set of dendrimer-drug conjugates as tumor therapeutic agents Bioconjugate Chem. 2010, 21, 1728-1743
27. Cheetham, A. G.; Zhang, P. C.; Lin, Y. A.; Lock, L. L.; Cui, H. G. Supramolecular nanostructures formed by anticancer drug assembly J. Am. Chem. Soc. 2013, 135, 2907-2910
28. Kasai, H.; Murakami, T.; Ikuta, Y.; Koseki, Y.; Baba, K.; Oikawa, H.; Nakanishi, H.; Okada, M.; Shoji, M.; Ueda, M.; Imahori, H.; Hashida, M. Creation of pure nanodrugs and their anticancer properties Angew. Chem., Int. Ed. 2012, 51, 10315-10318
29. Balland, V.; Byrdin, M.; Eker, A. P. M.; Ahmad, M.; Brettel, K. What makes the difference between a cryptochrome and DNA photolyase? A spectroelectrochemical comparison of the flavin redox transitions J. Am. Chem. Soc. 2009, 131, 426-427
30. Hu, Q. D.; Fan, H.; Ping, Y.; Liang, W. Q.; Tang, G. P.; Li, J. Cationic supramolecular nanoparticles for co-delivery of gene and anticancer drug Chem. Commun. 2011, 47, 5572-5574
31. Zhou, Y. F.; Huang, W.; Liu, J. Y.; Zhu, X. Y.; Yan, D. Y. Self-assembly of hyperbranched polymers and its biomedical applications Adv. Mater. 2010, 22, 4567-4590
32. Tang, R. P.; Ji, W. H.; Panus, D.; Palumbo, R. N.; Wang, C. Block copolymer micelles with acid-labile ortho ester side-chains: synthesis, characterization, and enhanced drug delivery to human glioma cells J. Controlled Release 2011, 151, 18-27
33. He, Q.; Gao, Y.; Zhang, L.; Zhang, Z.; Gao, F.; Ji, X.; Li, Y.; Shi, J. A pH-responsive mesoporous silica nanoparticles-based multi-drug delivery system for overcoming multi-drug resistance Biomaterials 2011, 32, 7711-7720
34. Gao, Z.; Zhang, L.; Sun, Y. Nanotechnology applied to overcome tumor drug resistance J. Controlled Release 2012, 162, 45-55
35. Hengartner, M. O. The biochemistry of apoptosis Nature 2000, 407, 770-776
36. Grütter, M. G. Caspases: key players in programmed cell death Curr. Opin. Struct. Biol. 2000, 10, 649-655